Repository logo
 

Evaluation of wild type and mutants of β-Glucuronidase (GUS) against natural and synthetic substrates

dc.contributor.advisorSanders, Daviden_US
dc.contributor.committeeMemberPalmer, Daviden_US
dc.contributor.committeeMemberUrquhart, Stephenen_US
dc.contributor.committeeMemberMueller, Jensen_US
dc.contributor.committeeMemberChelico, Lindaen_US
dc.creatorTiwari, Siddharthen_US
dc.date.accessioned2014-06-13T12:00:15Z
dc.date.available2014-06-13T12:00:15Z
dc.date.created2014-04en_US
dc.date.issued2014-06-12en_US
dc.date.submittedApril 2014en_US
dc.description.abstractModifying substrate specificity of β-glucuronidase (GUS) would be helpful in various enzyme prodrug systems in delivering drug dose to the site of action in the cancer treatment. Due to the presence of endogenous enzyme in human tissues, GUS-based Antibody-Directed Enzyme Prodrug Therapy (ADEPT) requires a novel substrate to avoid undesirable systemic activation. GUS is a glycosyl hydrolase, highly specific towards the glucuronide derivatives. It catalyzes the glycosidic cleavage of β-D-glucuronides to β-D-glucuronic acid and aglycone moiety. In order to gain insight on the substrate specificity of GUS, C6 carboxyl group of glucuronic acid was modified to C6 carboxamide (amide derivative). We have examined amide derivatized substrates with a variety of different aglycone groups including p-nitrophenyl, phenyl and 4-methylumbelliferone to further probe the activity profile of GUS. In an effort to optimize GUS activity, docking studies have been performed which indicated that amino acid point mutations near C6 carboxyl group of glucuronic acid could improve binding of the derivatized substrates. As a result point mutations to Arg-562 and Lys-568 which make the active site less positively charged either by glutamine or glutamate lead to an enzyme with much lower native substrate activity but abolished activity for the amide-derivatized substrate. This research study showed that there is still a further need of finding appropriate mutations required to make glucuronamide a better substrate for the mutated version of GUS.en_US
dc.identifier.urihttp://hdl.handle.net/10388/ETD-2014-04-1541en_US
dc.language.isoengen_US
dc.subjectβ-glucuronidase (GUS), Escherichia coli (E. coli), Glucaro-δ-lactam (GDL), p-nitrophenyl-β-D-Glucuronide (PNPG), p-nitrophenyl-β-D-Glucuronamide (PNPGun)en_US
dc.titleEvaluation of wild type and mutants of β-Glucuronidase (GUS) against natural and synthetic substratesen_US
dc.type.genreThesisen_US
dc.type.materialtexten_US
thesis.degree.departmentChemistryen_US
thesis.degree.disciplineChemistryen_US
thesis.degree.grantorUniversity of Saskatchewanen_US
thesis.degree.levelMastersen_US
thesis.degree.nameMaster of Science (M.Sc.)en_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
TIWARI-THESIS.pdf
Size:
2.53 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1009 B
Format:
Plain Text
Description: